Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge

Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June ... Read More